Roberto Matorras
Research Subjects
Roberto Matorras has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Antonia Exposito
Human Reproduction Unit, Cruces University Hospital, University of the Basque Country, Plaza de Cruces s/n Baracaldo (Vizcaya), 48903 Vizcaya, Spain
2 shared publications B Corcóstegui
2 shared publicationsF J Rodriguez-Escudero
2 shared publicationsF J Rodríguez-Escudero
2 shared publicationsFrancisco J Rodrı́guez-Escudero
2 shared publicationsJ C Fombellida
2 shared publications
Latest Publications
- 1 August 2011
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 28 (3) , 157-161
Prognostic value of serum progesterone and LH values on the day of hCG administration in IUI GnRH antagonist cycles
Objetive: to evaluate the effect of LH surge and progesterone rise in IUI cycles under gonadotropin stimulation with GnRH antagonist coadministration on pregnancy rates (PR). Study Design: The population under study consisted of 152 women prospectively studied and subjected to IUI. Results The higher the progesterone cutoff value, the lower the PR were 26.5% and 10.9% when the cutoff was 1 ng/mL, 26.0% and 8.6% when the cutoff was 1.2 ng/mL, 25.6% and 7.1% when the cutoff was 1.4 ng/mL and 25.3% and 0% when the cutoff was 1.6 ng/mL. Conclusion: In IUI cycles under GnRH antagonist coadministration, serum progesterone levels over 1.0 ng/mL are associated with lower PR, the higher the progesterone levels, the lower the PR.
- 1 August 2011
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 28 (3) , 157-161
Prognostic value of serum progesterone and LH values on the day of hCG administration in IUI GnRH antagonist cycles
Objetive: to evaluate the effect of LH surge and progesterone rise in IUI cycles under gonadotropin stimulation with GnRH antagonist coadministration on pregnancy rates (PR). Study Design: The population under study consisted of 152 women prospectively studied and subjected to IUI. Results The higher the progesterone cutoff value, the lower the PR were 26.5% and 10.9% when the cutoff was 1 ng/mL, 26.0% and 8.6% when the cutoff was 1.2 ng/mL, 25.6% and 7.1% when the cutoff was 1.4 ng/mL and 25.3% and 0% when the cutoff was 1.6 ng/mL. Conclusion: In IUI cycles under GnRH antagonist coadministration, serum progesterone levels over 1.0 ng/mL are associated with lower PR, the higher the progesterone levels, the lower the PR.
- Open Access
- 1 January 2011
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 26 (Supplement)
SELECTED ORAL COMMUNICATION SESSION, SESSION 70: ANDROLOGY AND SEMINAL FACTORS Wednesday 6 July 2011 14:00 - 15:45
Introduction: While sperm DNA Fragmentation (SDF) is a significant factor in the prognosis of male fertility, it has been noted that baseline levels of SDF sometimes vary when repeated ejaculates of the same individual are compared. The aim of this study was to analyze and compare both within and between individual baseline SDF fluctuations in two different groups of men; (1) those attending an infertility clinic for the purpose of seminal analysis and (2) those that donate fertile semen for artificial insemination programs.
- 1 January 2011
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 26 (Supplement)
Open AccessSELECTED ORAL COMMUNICATION SESSION, SESSION 70: ANDROLOGY AND SEMINAL FACTORS Wednesday 6 July 2011 14:00 - 15:45
Introduction: While sperm DNA Fragmentation (SDF) is a significant factor in the prognosis of male fertility, it has been noted that baseline levels of SDF sometimes vary when repeated ejaculates of the same individual are compared. The aim of this study was to analyze and compare both within and between individual baseline SDF fluctuations in two different groups of men; (1) those attending an infertility clinic for the purpose of seminal analysis and (2) those that donate fertile semen for artificial insemination programs.
- Open Access
- 1 July 2002
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 17 (7) , 1675
Bye-bye urinary gonadotrophins?: The use of urinary gonadotrophins should be discouraged
In view of concerns regarding the potential presence and infectivity of prion proteins in human urinary gonadotrophin preparations, together with the availability of both recombinant FSH and recombinant LH, it is argued that the use of urinary gonadotrophins should be discouraged.
- 1 July 2002
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 17 (7) , 1675
Open AccessBye-bye urinary gonadotrophins?: The use of urinary gonadotrophins should be discouraged
In view of concerns regarding the potential presence and infectivity of prion proteins in human urinary gonadotrophin preparations, together with the availability of both recombinant FSH and recombinant LH, it is argued that the use of urinary gonadotrophins should be discouraged.
- 1 February 2002
- Published by Elsevier in Fertility and Sterility
- Vol. 77 (2) , 303-308
Recurrence of endometriosis in women with bilateral adnexectomy (with or without total hysterectomy) who received hormone replacement therapy
- 1 February 2002
- Published by Elsevier in Fertility and Sterility
- Vol. 77 (2) , 303-308
Recurrence of endometriosis in women with bilateral adnexectomy (with or without total hysterectomy) who received hormone replacement therapy
- 1 November 2001
- Published by Elsevier in Fertility and Sterility
- Vol. 76 (5) , 923-928
Women who are not exposed to spermatozoa and infertile women have similar rates of stage I endometriosis
- 1 November 2001
- Published by Elsevier in Fertility and Sterility
- Vol. 76 (5) , 923-928
Women who are not exposed to spermatozoa and infertile women have similar rates of stage I endometriosis
- 1 January 2000
- Vol. 79 (1) , 86-7
Fulminating gastric cancer in a pregnant woman, after 18 weeks of gestation, recipient of oocytes.
- 1 January 2000
- Vol. 79 (1) , 86-7
Fulminating gastric cancer in a pregnant woman, after 18 weeks of gestation, recipient of oocytes.
- 6 August 1998
- Vol. 43 (3) , 171-6
Total immunoreactive alpha-inhibin in human seminal plasma, sperm quality, and in vitro fertilization rates.
To assess the relationship between the concentrations of total immunoreactive alpha-inhibin in human seminal plasma, sperm quality, and in vitro fertilization (IVF) rates. Medical school hospital. Prospective study. 72 consecutive couples undergoing IVF with husband's sperm in which at least 4 oocytes were obtained. Alpha-inhibin determination by means of enzyme-linked immunosorbent assay, sperm analysis for density and motility, IVF rates. Total immunoreactive alpha-inhibin levels were not correlated with IVF rates. Nor were there any differences in fertilization rates in the different groups. Lower inhibin levels were found in oligozoospermic cases. Lower sperm counts were found in cases with inhibin values below the median value, and also with respect to various other cutoffs. No correlation was found between inhibin levels and any of the sperm variables measured. Total immunoreactive alpha-inhibin is not a prognostic factor in IVF cycles. However, an association was found between inhibin and sperm concentration, suggesting that alpha-inhibin in the human seminal fluid could be a marker for some aspects of spermatogenesis.
- 6 August 1998
- Vol. 43 (3) , 171-6
Total immunoreactive alpha-inhibin in human seminal plasma, sperm quality, and in vitro fertilization rates.
To assess the relationship between the concentrations of total immunoreactive alpha-inhibin in human seminal plasma, sperm quality, and in vitro fertilization (IVF) rates. Medical school hospital. Prospective study. 72 consecutive couples undergoing IVF with husband's sperm in which at least 4 oocytes were obtained. Alpha-inhibin determination by means of enzyme-linked immunosorbent assay, sperm analysis for density and motility, IVF rates. Total immunoreactive alpha-inhibin levels were not correlated with IVF rates. Nor were there any differences in fertilization rates in the different groups. Lower inhibin levels were found in oligozoospermic cases. Lower sperm counts were found in cases with inhibin values below the median value, and also with respect to various other cutoffs. No correlation was found between inhibin levels and any of the sperm variables measured. Total immunoreactive alpha-inhibin is not a prognostic factor in IVF cycles. However, an association was found between inhibin and sperm concentration, suggesting that alpha-inhibin in the human seminal fluid could be a marker for some aspects of spermatogenesis.
- 1 January 1998
- Vol. 25, 29-31
Agreement between hysterosalpingography and laparoscopic chromopertubation in assessment of tubal patency.
To assess the agreement between tubal patency assessed by laparoscopy with chromopertubation and by hysterosalpingography using contrast media. University Medical School. 314 consecutive women subjected to laparoscopy and hysterosalpingography for an infertility study. Prospective study. Chromopertubation using Methylen blue dye, performed on days 20-24. Hysterosalpingography performed on days 7-10 with water soluble contrast. Kappa coefficient calculation. Kappa coefficient ranged from 0.40 to 0.36, depending on the categories analyzed, corresponding to a fair agreement. The diagnosis of tubal factor requires that both tubal patency tests (Hysterosalpingography and laparoscopy) show an abnormal patency. When one of the aforementioned tests is normal, performing the second one has little clinical advantage. However, it is suggested that when there is a discordant patency the pregnancy rates could be somewhat reduced.
- 1 January 1998
- Vol. 25, 29-31
Agreement between hysterosalpingography and laparoscopic chromopertubation in assessment of tubal patency.
To assess the agreement between tubal patency assessed by laparoscopy with chromopertubation and by hysterosalpingography using contrast media. University Medical School. 314 consecutive women subjected to laparoscopy and hysterosalpingography for an infertility study. Prospective study. Chromopertubation using Methylen blue dye, performed on days 20-24. Hysterosalpingography performed on days 7-10 with water soluble contrast. Kappa coefficient calculation. Kappa coefficient ranged from 0.40 to 0.36, depending on the categories analyzed, corresponding to a fair agreement. The diagnosis of tubal factor requires that both tubal patency tests (Hysterosalpingography and laparoscopy) show an abnormal patency. When one of the aforementioned tests is normal, performing the second one has little clinical advantage. However, it is suggested that when there is a discordant patency the pregnancy rates could be somewhat reduced.
- 1 July 1994
- Vol. 39 (4) , 223-8
Human seminal plasma analysis of five tumor markers: CA 125, alpha-fetoprotein, CA 50, CA 19.9, and CA 195.
To evaluate tumor markers in seminal plasma and their possible relationship with fertility. Five different tumor markers (alpha-fetoprotein, CA 125, CA 19.9, CA 50, and CA195) were studied in seminal plasma and serum from 42 males (14 volunteers from semen donation and 28 males from infertile couples). CA 50 and CA 19.9 levels were more than 300 times as high in seminal plasma as in serum (4,396.4 U/mL vs. 13.9 and 3,893.5 U/mL vs. 11.5). CA 125 levels were 14 times as high in seminal fluid as in serum (217.2 U/mL vs. 15.1), and CA 195 levels 22 times as high (122.5 U/mL vs. 5.6). alpha-Fetoprotein levels in seminal plasma were one-third those in serum (0.75 ng/mL vs. 2.47). Seminal levels of CA 125, CA 50, and CA 19.9 were correlated with the duration of infertility. Compared with donors, among seminal fluids from infertile couples there was a trend to higher levels of CA 19.9 and CA 125. CA 125 levels were lower in samples having normal sperm counts, and CA 125 and CA 19.9 levels were lower among couples who conceived compared with those who did not conceive. Tumor markers, either in seminal plasma or in serum, were not found to be correlated with semen characteristics. It appears that seminal levels of the tumor markers studied depend on more factors than the single serum concentration. The biological significance of the high seminal levels of the four carbohydrate antigens, and the association of low levels of CA 125 and CA 19.9 and fertility, could not be determined from our study. It is suggested, however, that CA 125 and CA 19.9 could be used as seminal plasma markers of fertility.
- 1 July 1994
- Vol. 39 (4) , 223-8
Human seminal plasma analysis of five tumor markers: CA 125, alpha-fetoprotein, CA 50, CA 19.9, and CA 195.
To evaluate tumor markers in seminal plasma and their possible relationship with fertility. Five different tumor markers (alpha-fetoprotein, CA 125, CA 19.9, CA 50, and CA195) were studied in seminal plasma and serum from 42 males (14 volunteers from semen donation and 28 males from infertile couples). CA 50 and CA 19.9 levels were more than 300 times as high in seminal plasma as in serum (4,396.4 U/mL vs. 13.9 and 3,893.5 U/mL vs. 11.5). CA 125 levels were 14 times as high in seminal fluid as in serum (217.2 U/mL vs. 15.1), and CA 195 levels 22 times as high (122.5 U/mL vs. 5.6). alpha-Fetoprotein levels in seminal plasma were one-third those in serum (0.75 ng/mL vs. 2.47). Seminal levels of CA 125, CA 50, and CA 19.9 were correlated with the duration of infertility. Compared with donors, among seminal fluids from infertile couples there was a trend to higher levels of CA 19.9 and CA 125. CA 125 levels were lower in samples having normal sperm counts, and CA 125 and CA 19.9 levels were lower among couples who conceived compared with those who did not conceive. Tumor markers, either in seminal plasma or in serum, were not found to be correlated with semen characteristics. It appears that seminal levels of the tumor markers studied depend on more factors than the single serum concentration. The biological significance of the high seminal levels of the four carbohydrate antigens, and the association of low levels of CA 125 and CA 19.9 and fertility, could not be determined from our study. It is suggested, however, that CA 125 and CA 19.9 could be used as seminal plasma markers of fertility.
- 1 January 1994
- Vol. 21 (1) , 38-44
Factors that influence the outcome of the intrauterine insemination with husband's sperm.
A retrospective analysis was undertaken in 160 intrauterine insemination with husband's sperm (IUIH) cycles, performed in 45 couples. The male factor represented the main indication (80%). Women who conceived had a lower duration of infertility (4.4 years +/- 3.0 vs 7.7 +/- 2.98). A significantly and pardoxically lower motility (3+ and 2+) was observed in raw specimens within conceptional cycles. However in prepared specimens in conceptional cycles the percentage of motility 3+ and 2+ was significantly increased (80.6% +/- 8.1 versus 70.7% +/- 20.2). The most significant difference was found in regard to a better response to preparation among conceptional cycles, expressed as the percentual increase in motility 3+ and 2+ (55.6% +/- 3.9 vs 41.3% +/- 19.4).
- 1 January 1994
- Vol. 21 (1) , 38-44
Factors that influence the outcome of the intrauterine insemination with husband's sperm.
A retrospective analysis was undertaken in 160 intrauterine insemination with husband's sperm (IUIH) cycles, performed in 45 couples. The male factor represented the main indication (80%). Women who conceived had a lower duration of infertility (4.4 years +/- 3.0 vs 7.7 +/- 2.98). A significantly and pardoxically lower motility (3+ and 2+) was observed in raw specimens within conceptional cycles. However in prepared specimens in conceptional cycles the percentage of motility 3+ and 2+ was significantly increased (80.6% +/- 8.1 versus 70.7% +/- 20.2). The most significant difference was found in regard to a better response to preparation among conceptional cycles, expressed as the percentual increase in motility 3+ and 2+ (55.6% +/- 3.9 vs 41.3% +/- 19.4).